ArticleCancer cell2022

Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma.

Romanos Sklavenitis-Pistofidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.